The development of innovative treatments for infectious diseases such as hepatitis B and tuberculosis as well as for human papillomavirus-induced cancer will get a boost thanks to a new €20 million loan to French biopharmaceutical company Transgene SA, provided by the InnovFin Infectious Diseases (ID) facility.
from EUROPA - Syndicated Research News Feed http://ift.tt/1PCwpmF
via IFTTT
No comments:
Post a Comment